Weekly Cyclophosphamide and Alternate-Day Prednisone: An Effective, Convenient, and Well-Tolerated Oral Treatment for Relapsed Multiple Myeloma After Autologous Stem Cell Transplantation-Reference-Cited by-同舟云学术

Weekly Cyclophosphamide and Alternate-Day Prednisone: An Effective, Convenient, and Well-Tolerated Oral Treatment for Relapsed Multiple Myeloma After Autologous Stem Cell Transplantation

Published:2005-12 Issue:12 Volume:80 Page:1578-1582
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Trieu Young,Trudel Suzanne,Pond Gregory R.,Mikhael Joseph,Jaksic Wilfrid,Reece Donna E.,Chen Christine I.,Stewart A. Keith

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. The role of high-dose chemotherapy and stem-cell transplantation in patients with multiple myeloma: a practice guideline of the Cancer Care Ontario Practice Guidelines Initiative;Imrie;Ann Intern Med,2002

2. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med,1996

3. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med,2003

4. Cyclophosphamide vs melphalan in treatment of plasma cell myeloma;Rivers;JAMA,1969

5. Factors responsible for bone marrow toxicity after treatment of myeloma patients with different alkylating agents;Ringborg;Acta Med Scand,1978

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives;Critical Reviews in Oncology/Hematology;2023-07

2. The Nitrogen Mustards;Pharmacological Reviews;2022-06-16

3. Oral Therapies for Multiple Myeloma;Oncology & Haematology;2022

4. Multiple Myeloma;Oncology in the Precision Medicine Era;2019-12-18

5. Addition of Cyclophosphamide “On Demand” to Lenalidomide and Corticosteroids in Patients With Relapsed/Refractory Multiple Myeloma—A Retrospective Review of a Single-center Experience;Clinical Lymphoma Myeloma and Leukemia;2019-04